The Heart of the Matter: Optimizing Launch for Cardiovascular Drugs 

Dr taking patient blood pressure

Heart disease is a leading cause of death globally, yet the journey to market for new medicines and devices in this therapeutic area is becoming more complex. High development costs, increased scrutiny by regulators and payers, and hurdles to market access are just a few of the challenges you will face, but with the right resources you can streamline the launch process and demonstrate value for your products clinically and commercially.

Tap into an extended network of cardiovascular experts and research solutions

  • Access to a global team of cardiovascular specialists who advise you at every step pre-and-post launch
  • Guidance to achieve scientific differentiation and fulfill regulatory requirements
  • Data and analytics tools to help you identify and assess market opportunities
  • Global patient reported outcomes data on more than 165 conditions
  • Brand/promotional assessment and support for long-term commercial effectiveness


Learn more about our research solutions.

Edge of Insight: Connecting with the mHealth Consumer

man using wireless blood pressure monitorWeb-connected devices and applications enable a future in which healthcare professionals will have easy access to relevant patient health data. In this report Kantar Health combined its experience with patient outcomes with its expertise in healthcare innovations to take a closer look at who is using mHealth technology, why they are using it, and how it is affecting their lives.

Download Report

National Health and Wellness Survey

man looking through telescopeKantar Health’s National Health and Wellness Survey (NHWS) is the largest global self-reported general population survey in the healthcare industry. NHWS provides disease-specific measures that help you size market opportunities, measure direct and indirect costs, and gain disease-specific insights to optimize the value proposition and inform brand strategies.

Download Fact Sheet